EMEND IV 150 MG

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG

Pieejams no:

MERCK SHARP & DOHME ISRAEL LTD

ATĶ kods:

A04AD12

Zāļu forma:

POWDER FOR SOLUTION FOR INFUSION

Ievadīšanas:

I.V

Ražojis:

MERCK SHARP & DOHME B.V, HOLLAND

Ārstniecības grupa:

APREPITANT

Ārstēšanas norādes:

Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Autorizācija datums:

2011-11-01